Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET

Journal:
Journal of Biological Chemistry
Published:
DOI:
10.1016/j.jbc.2021.100641
Affiliations:
3
Authors:
11
Institutions Authors Share
Janssen Research & Development, LLC (J&J PRD), United States of America (USA)
6.000000
0.55
Genmab B.V., Netherlands
4.000000
0.36
University Medical Center Schleswig-Holstein - Campus Kiel (UKSH Kiel), Germany
1.000000
0.09